Showing 681 - 700 results of 27,414 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 50 ((mg decrease) OR (mean decrease)) ))', query time: 0.98s Refine Results
  1. 681
  2. 682

    Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

    Published 2013
    “…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC<sub>50</sub> concentration of fenretinide during different time points (24–48–72 hours). …”
  3. 683
  4. 684
  5. 685

    Pre-treatment with CDDO-Me decreases IR-induced DNA damage in a variety of non-cancerous cells. by Mariam El-Ashmawy (678638)

    Published 2014
    “…Data analyzed and calculated using Open Comet software [tail moment = tail length x tail DNA percentage]. Mean ± SEM of >50 cells per condition, *p<0.05 using t-test (compared to 3 Gy DMSO). …”
  6. 686
  7. 687

    Decreased remyelination initiation is observed in Scribble cKO mice following focal demyelination in corpus callosum. by Andrew A. Jarjour (343100)

    Published 2015
    “…<i>n</i> = 3 mice per genotype. * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001 versus Scrib WT CL. Scale bars: A,B,D,E: 2 μm. J,K: 50 μm.</p>…”
  8. 688
  9. 689

    A-p50 affects A549 cell survival through inhibition of NF-κB-mediated transcriptional activation by Jing Mi (18654)

    Published 2011
    “…Ad-A-p50 virus-injected tumor tissues show a decrease in Ki67 protein expression compared with Ad-siNT-injected tumor tissues (×100 magnification, brownish red nuclear stain), consistent with a decrease in cell proliferation. …”
  10. 690

    Decreased Platelet Count in Patients Receiving Continuous Veno-Venous Hemofiltration: A Single-Center Retrospective Study by Buyun Wu (563610)

    Published 2014
    “…<div><p>Background</p><p>A decreased platelet count may occur and portend a worse outcome in patients receiving continuous renal replacement therapy (CRRT). …”
  11. 691
  12. 692
  13. 693

    Supplementary Material for: Use of the Myocardial Performance Index in Decreased Fetal Movement Assessment: A Case-Control Study by Ho D. (4108837)

    Published 2017
    “…<p><b><i>Objectives:</i></b> To determine whether there are any fetal cardiac function changes, as measured by the myocardial performance index (MPI), in pregnancies complicated by decreased fetal movement (DFM). <b><i>Methods:</i></b> We performed a prospective cross-sectional case-control study of 50 DFM and 50 uncomplicated third-trimester pregnancies matched within 2 gestational weeks. …”
  14. 694
  15. 695

    Multifunctional Hybrid Compounds Derived from 2‑(2,5-Dioxopyrrolidin-1-yl)-3-methoxypropanamides with Anticonvulsant and Antinociceptive Properties by Michał Abram (4490902)

    Published 2017
    “…Such hybrids demonstrated effectiveness in two of the most widely used animal seizure models, namely, the maximal electroshock (MES) test and the psychomotor 6 Hz (32 mA) seizure models. Compound <b>33</b> showed the highest anticonvulsant activity in these models (ED<sub>50</sub> MES = 79.5 mg/kg, ED<sub>50</sub> 6 Hz = 22.4 mg/kg). …”
  16. 696
  17. 697
  18. 698
  19. 699
  20. 700